INTERNATIONAL MULTICENTRIC TEST FOR THE EVALUATION OF A COMBINED TABLET OF FOUR DRUGS AT DAILY FIXED DOSE IN THE INTENSIVE INITIAL PHASE (2 MONTHS) OF CHEMOTHERAPY FOLLOWED BY A COMBINED TABLET OF TWO DRUGS AT A FIXED DOSE THREE TIMES A WEEK IN THE CONTINUATION PHASE (4 MONTHS) FOR THE TREATMENT OF PULMONARY TUBERCULOSIS

Not Applicable

• Conditions: -A150 Tuberculosis of lung, confirmed by sputum microscopy with or without culture; Tuberculosis of lung, confirmed by sputum microscopy with or without culture; A150

• Registration Number: PER-093-03
• Lead Sponsor: nion Internacional contra TBC y enfermedades pulmonares,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2004-03-31
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Not contemplated

Exclusion Criteria

Not contemplated

Study & Design

• Study Type: Interventional
• Study Design: Not specified